Telomere Shortening

2

Review clinical trials related to Telomere Shortening. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

TA-65 and Aging Associated Microvascular Dysfunction

The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.

Participants needed: 180
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Medical College of WisconsinUpdated: May 1, 2026
Eligibility criteria

Healthy Adults 18 - 35 and 65+ years of age [+1]

36-64 years of age without clinical diagnosis of CAD [+23]

Status: Recruiting

Biological and Behavioral Outcomes of Community Nature Walks

The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. The first consists of community nature walks in a pristine redwood forest for six months. This is followed by chosen nature activities with family and/or friends for three months. The investigators will test the ability of these activities in nature to reduce chronic stress that underpins many health disparities using validated biological, behavioral, and sociocultural measures. The use of these measures is in alignment with the National Institute of Minority Health and Health Disparities (NIMHD) Research Framework, and will increase understanding of individual, interpersonal, community, and social level factors that lead to, and that can eliminate health disparities.

Participants needed: 200
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Charlotte TateUpdated: Sep 28, 2023Locations: 1
Eligibility criteria

18 years or older [+3]

pregnant women (and other gender identities who are pregnant) [+2]